2013
Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population.
Akselrod H, Grau LE, Barbour R, Heimer R. Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population. American Journal Of Public Health 2013, 104: 1713-21. PMID: 24134382, PMCID: PMC3990658, DOI: 10.2105/ajph.2013.301357.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis B virusDrug use durationSubstance abuse treatmentB virusRisk factorsCriminal justice involvementDrug usersAbuse treatmentAdult injection drug usersSeroprevalence of HIVInjection drug usePotential risk factorsSignificant predictorsUse durationMultiple viral infectionsEffective harm reduction strategiesHarm reduction strategiesJustice involvementHCV seroprevalenceInjection useInterim analysisViral infectionDrug useSerological testsAssociations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA
Heimer R, Barbour R, Palacios WR, Nichols LG, Grau LE. Associations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA. AIDS And Behavior 2013, 18: 452-463. PMID: 23921583, PMCID: PMC3917972, DOI: 10.1007/s10461-013-0572-3.Peer-Reviewed Original ResearchMeSH KeywordsAdultConnecticutDrug UsersFemaleHarm ReductionHealth Services AccessibilityHumansInterviews as TopicLongitudinal StudiesMaleNeedle SharingPrevalenceResidence CharacteristicsRisk FactorsSocial EnvironmentSocioeconomic FactorsSubstance Abuse, IntravenousSubstance-Related DisordersSuburban Health ServicesSuburban PopulationYoung AdultConceptsHarm reduction servicesInjection riskReduction servicesAbuse treatmentInjection drug useInjection drug usersRisky injection practicesPoor social supportDisadvantaged census tractsSubstance abuse treatmentDrug abuse treatmentPatterns of heroinRespondent-driven samplingHepatitis BInfluence of residenceSevere depressionOpioid overdosesSerological testingOverdose deathsGeneral populationInjection practicesDrug usersDrug useYounger ageRisk behaviors
2010
Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability
Cepeda JA, Odinokova VA, Heimer R, Grau LE, Lyubimova A, Safiullina L, Levina OS, Niccolai LM. Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability. AIDS And Behavior 2010, 15: 1003-1010. PMID: 20872063, PMCID: PMC3112286, DOI: 10.1007/s10461-010-9816-7.Peer-Reviewed Original ResearchHIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation
Grau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, Heimer R. HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation. AIDS And Behavior 2010, 15: 45-57. PMID: 20700645, PMCID: PMC3023022, DOI: 10.1007/s10461-010-9775-z.Peer-Reviewed Original Research
2007
Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”?
Grau LE, Dasgupta N, Harvey A, Irwin K, Givens A, Kinzly M, Heimer R. Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”? American Journal On Addictions 2007, 16: 166-173. PMID: 17612819, DOI: 10.1080/10550490701375293.Peer-Reviewed Original Research
2004
Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities
Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R, Team T. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction 2004, 99: 1136-1146. PMID: 15317634, DOI: 10.1111/j.1360-0443.2004.00694.x.Peer-Reviewed Original Research